Membrane-perturbing effect of fatty acids and lysolipids

Progress in Lipid Research

Volumn 52, Issue 1, 2013, Pages 130-140

  Arouri, Ahmad ^a   Mouritsen, Ole G ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Fatty acid; Lipid membranes; Lysolipid; Membrane perturbation; Permeability enhancing effect; Secretory phospholipase A2 (sPLA 2)

Indexed keywords

CHOLESTEROL; DOXORUBICIN; FATTY ACID DERIVATIVE; LIPID; LIPOSOME; LYSOLIPID DERIVATIVE; SECRETORY PHOSPHOLIPASE A2; UNCLASSIFIED DRUG;

CELL MEMBRANE PERMEABILITY; CYTOTOXICITY; DRUG FORMULATION; DRUG RELEASE; HUMAN; LIPID BILAYER; LIPID MEMBRANE; LIPOSOMAL DELIVERY; NONHUMAN; PERMEABILITY BARRIER; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS;

CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DRUG DELIVERY SYSTEMS; FATTY ACIDS; LIPID BILAYERS; LIPOSOMES; MEMBRANE LIPIDS;

EID: 84870213151     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2012.09.002     Document Type: Review

References (154)

1. O.G. Mouritsen Life-as a matter of fat: the emerging science of lipidomics 2005 Springuer-Verlag Berlin-Heidelberg-New York
2. K. Simons The biology of lipids: trafficking, regulation, and function 2011 Cold Spring Harbor Laboratory Press Woodbury, NY
3. A. Blume Lipids D. Walz, J. Teissie, G. Milazzo, Bioelectrochemistry of membranes 2004 Birkhäuser Verlag Basel 60 152
4. S.J. Singer, and G.L. Nicolson The fluid mosaic model of the structure of cell membranes Science 175 1972 720 731
5. L.A. Bagatolli, J.H. Ipsen, A.C. Simonsen, and O.G. Mouritsen An outlook on organization of lipids in membranes: searching for a realistic connection with the organization of biological membranes Prog Lipid Res 49 2010 378 389
6. D.M. Engelman Membranes are more mosaic than fluid Nature 438 2005 578 580
7. K. Matsumoto, J. Kusaka, A. Nishibori, and H. Hara Lipid domains in bacterial membranes Mol Microbiol 61 2006 1110 1117
8. P.J. Quinn A lipid matrix model of membrane raft structure Prog Lipid Res 49 2010 390 406
9. Y.M. Zhang, and C.O. Rock Membrane lipid homeostasis in bacteria Nat Rev Microbiol 6 2008 222 233
10. P.J. Quinn Lipid-lipid interactions in bilayer membranes: married couples and casual liaisons Prog Lipid Res 51 2012 179 198
11. R. Phillips, T. Ursell, P. Wiggins, and P. Sens Emerging roles for lipids in shaping membrane-protein function Nature 459 2009 379 385
12. J.M. Sanderson Peptide-lipid interactions: insights and perspectives Org Biomol Chem 3 2005 201 212
13. K.A. Brogden Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3 2005 238 250
14. J. Chen, D. Korostyshevsky, S. Lee, and E.O. Perlstein Accumulation of an antidepressant in vesiculogenic membranes of yeast cells triggers autophagy PLoS One 7 2012 e34024
15. T. Heimburg, and A.D. Jackson The thermodynamics of general anesthesia Biophys J 92 2007 3159 3165
16. J. Perez-Gil BBA special issue: protein modulation of membrane structure Biochim Biophys Acta 1778 2008 1527 1696
17. O.GPlease supply a page range for the Ref.[17] Mouritsen Model answers to lipid membrane questions Cold Spring Harb Perspect Biol 3 2011 a004622
18. A. Arouri, M. Dathe, and A. Blume Peptide induced demixing in PG/PE lipid mixtures: a mechanism for the specificity of antimicrobial peptides towards bacterial membranes? Biochim Biophys Acta 1788 2009 650 659
19. A. Arouri, V. Kiessling, L. Tamm, M. Dathe, and A. Blume Morphological changes induced by the action of antimicrobial peptides on supported lipid bilayers J Phys Chem B 115 2011 158 167
20. K. Lohner, E. Sevcsik, G. Pabst, and A.L. Liu Liposome-based biomembrane mimetic systems: implications for lipid-peptide interactions Adv Planar Lipid Bilayers Liposomes 6 2008 103 137
21. K. Farsad, and P. De Camilli Mechanisms of membrane deformation Curr Opin Cell Biol 15 2003 372 381
22. T. Itoh, and T. Takenawa Mechanisms of membrane deformation by lipid-binding domains Prog Lipid Res 48 2009 298 305
23. H.T. McMahon, and J.L. Gallop Membrane curvature and mechanisms of dynamic cell membrane remodelling Nature 438 2005 590 596
24. J. Zimmerberg, and M.M. Kozlov How proteins produce cellular membrane curvature Nat Rev Mol Cell Biol 7 2006 9 19
25. L. Tamm Comprehensive biophysics E. Egelman, Membranes 2012 Academic Press Amsterdam;Waltham, MA vol. 5
26. L.K. Tamm Protein-lipid interactions: from membrane domains to cellular networks 2005 WILEY-VCH Verlag GmbH & Co. KGaA Weinheim, Germany
27. Y. Barenholz Liposome application: problems and prospects Curr Opin Colloid Interface Sci 6 2001 66 77
28. D.B. Fenske, and P.R. Cullis Liposomal nanomedicines Expert Opin Drug Deliv 5 2008 25 44
29. G. Storm, and D.J.A. Crommelin Liposomes: quo vadis? Pharm Sci Technol Today 1 1998 19 31
30. G. Fricker, T. Kromp, A. Wendel, A. Blume, J. Zirkel, and H. Rebmann Phospholipids and lipid-based formulations in oral drug delivery Pharm Res 27 2010 1469 1486
31. H. Hillaireau, and P. Couvreur Nanocarriers' entry into the cell: relevance to drug delivery Cell Mol Life Sci 66 2009 2873 2896
32. O. Harush-Frenkel, Y. Altschuler, and S. Benita Nanoparticle-cell interactions: drug delivery implications Crit Rev Ther Drug Carrier Syst 25 2008 485 544
33. F. Bray, A. Jemal, N. Grey, J. Ferlay, and D. Forman Global cancer transitions according to the human development index (2008-2030): a population-based study Lancet Oncol 13 2012 790 801
34. T. Kaasgaard, and T.L. Andresen Liposomal cancer therapy: exploiting tumor characteristics Expert Opin Drug Deliv 7 2010 225 243
35. M. Das, C. Mohanty, and S.K. Sahoo Ligand-based targeted therapy for cancer tissue Expert Opin Drug Deliv 6 2009 285 304
36. Y. Malam, M. Loizidou, and A.M. Seifalian Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer Trends Pharmacol Sci 30 2009 592 599
37. J.O. You, D. Almeda, G.J. Ye, and D.T. Auguste Bioresponsive matrices in drug delivery J Biol Eng 4 2010 15
38. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res 46 1986 6387 6392
39. T.L. Andresen, S.S. Jensen, and K. Jorgensen Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release Prog Lipid Res 44 2005 68 97
40. C.D. Landon, J.-Y. Park, D. Needham, and M.W. Dewhirst Nanoscale drug delivery and hyperthermia: the materials design and preclinical and clinical testing of low temperature-sensitive liposomes used in combination with mild hyperthermia in the treatment of local cancer Open Nanomed J 3 2011 38 64
41. A. Arouri, and O.G. Mouritsen Phospholipase A2-susceptible liposomes of anticancer double lipid-prodrugs Eur J Pharm Sci 45 2012 408 420
42. A. Schroeder, J. Kost, and Y. Barenholz Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes Chem Phys Lipids 162 2009 1 16
43. M.R. Preiss, and G.D. Bothun Stimuli-responsive liposome-nanoparticle assemblies Expert Opin Drug Deliv 8 2011 1025 1040
44. O.G. Mouritsen Lipids, curvature, and nano-medicine Eur J Lipid Sci Technol 113 2011 1174 1187
45. J.E. Burke, and E.A. Dennis Phospholipase A2 structure/function, mechanism, and signaling J Lipid Res 50 Suppl 2009 S237 S242
46. M. Murakami, Y. Taketomi, Y. Miki, H. Sato, T. Hirabayashi, and K. Yamamoto Recent progress in phospholipase A(2) research: from cells to animals to humans Prog Lipid Res 50 2011 152 192
47. D.A. Six, and E.A. Dennis The expanding superfamily of phospholipase A2 enzymes: classification and characterization Biochim Biophys Acta 1488 2000 1 19
48. I. Kudo Diversity of phospholipase A2 enzymes Biol Pharm Bull 27 2004 1158 1164
49. M. Murakami, and I. Kudo New phospholipase A(2) isozymes with a potential role in atherosclerosis Curr Opin Lipidol 14 2003 431 436
50. D. Hui Phospholipase A(2) enzymes in metabolic and cardiovascular diseases Curr Opin Lipidol 23 2012 235 240
51. A.D. Tselepis, and M. John Chapman Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase Atherosclerosis (Suppl) 3 2002 57 68
52. K. Murata, H. Egami, H. Kiyohara, S. Oshima, T. Kurizaki, and M. Ogawa Expression of group-II phospholipase A2 in malignant and non-malignant human gastric mucosa Br J Cancer 68 1993 103 111
53. L. Tribler, L.T. Jensen, K. Jorgensen, N. Brunner, M.H. Gelb, and H.J. Nielsen Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue Anticancer Res 27 2007 3179 3185
54. K.F. Scott, M. Sajinovic, J. Hein, S. Nixdorf, P. Galettis, and W. Liauw Emerging roles for phospholipase A2 enzymes in cancer Biochimie 92 2010 601 610
55. J.-J. Hu, G. Tian, and N. Zhang Cytosolic phospholipase A(2) and its role in cancer Clin Oncol Cancer Res 8 2011 71 76
56. G.S. Belinsky, T.V. Rajan, E.A. Saria, C. Giardina, and D.W. Rosenberg Expression of secretory phospholipase A2 in colon tumor cells potentiates tumor growth Mol Carcinog 46 2007 106 116
57. Q. Cai, Z. Zhao, C. Antalis, L. Yan, G. Del Priore, and A.H. Hamed Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer FASEB J 26 2012 3306 3320
58. G. Tosato, M. Segarra, and O. Salvucci Cytosolic phospholipase A2(alpha) and cancer: a role in tumor angiogenesis J Natl Cancer Inst 102 2010 1377 1379
59. T. Yano, D. Fujioka, Y. Saito, T. Kobayashi, T. Nakamura, and J.E. Obata Group V secretory phospholipase A2 plays a pathogenic role in myocardial ischaemia-reperfusion injury Cardiovasc Res 90 2011 335 343
60. C.B. Wright, Y. Moon, M.C. Paik, T.R. Brown, L. Rabbani, and M. Yoshita Inflammatory biomarkers of vascular risk as correlates of leukoariosis Stroke 40 2009 3466 3471
61. O.G. Mouritsen, T.L. Andresen, A. Halperin, P.L. Hansen, A.F. Jakobsen, and U.B. Jensen Activation of interfacial enzymes at membrane surfaces J Phys: Condens Matter 18 2006 1293 1304
62. P.J. Pedersen, S.K. Adolph, A.K. Subramanian, A. Arouri, T.L. Andresen, and O.G. Mouritsen Liposomal formulation of retinoids designed for enzyme triggered release J Med Chem 53 2010 3782 3792
63. M.J.A. de Jonge, M. Slingerland, W.J. Loos, E.A.C. Wiemer, H. Burger, and R.H.J. Mathijssen Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation Eur J Cancer 46 2010 3016 3021
64. J. Davidsen, K. Jorgensen, T.L. Andresen, and O.G. Mouritsen Secreted phospholipase A2 as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissue Biochim Biophys Acta 1609 2003 95 101
65. J. Davidsen, O.G. Mouritsen, and K. Jorgensen Synergistic permeability enhancing effect of lysophospholipids and fatty acids on lipid membranes Biochim Biophys Acta 1564 2002 256 262
66. H. Jespersen, J.H. Andersen, H.J. Ditzel, and O.G. Mouritsen Lipids, curvature stress, and the action of lipid prodrugs: free fatty acids and lysolipid enhancement of drug transport across liposomal membranes Biochimie 94 2012 2 10
67. N. Rasmussen, J.H. Andersen, H. Jespersen, O.G. Mouritsen, and H.J. Ditzel Effect of free fatty acids and lysolipids on cellular uptake of doxorubicin in human breast cancer cell lines Anticancer Drugs 21 2010 674 677
68. P. Hoyrup, J. Davidsen, and K. Jorgensen Lipid membrane partitioning of lysolipids and fatty acids: effects of membrane phase structure and detergent chain lengths J Phys Chem B 105 2001 2649 2657
69. M. Grit, and D.J.A. Crommelin The effect of aging on the physical stability of liposome dispersions Chem Phys Lipids 62 1992 113 122
70. M.K. Jain, and G.H. De Haas Structure of 1-acyl lysophosphatidylcholine and fatty acid complex in bilayers Biochim Biophys Acta 642 1981 203 211
71. M.K. Jain, C.J. van Echteld, F. Ramirez, J. de Gier, G.H. de Haas, and L.L. van Deenen Association of lysophosphatidylcholine with fatty acids in aqueous phase to form bilayers Nature 284 1980 486 487
72. K. Inoue, and T. Kitagawa Effect of exogenous lysolecithin on liposomal membranes its relation to membrane fluidity Biochim Biophys Acta 363 1974 361 372
73. B.D. McKersie, J.H. Crowe, and L.M. Crowe Free fatty-acid effects on leakage, phase properties and fusion of fully hydrated model membranes Biochim Biophys Acta 982 1989 156 160
74. C.J.A. Van Echteld, B. De Kruijff, J.G. Mandersloot, and J. De Gier Effects of lysophosphatidylcholines on phosphatidylcholine and phosphatidylcholine/cholesterol liposome systems as revealed by 31P-NMR, electron microscopy and permeability studies Biochim Biophys Acta 649 1981 211 220
75. 2+/palmitic acid complexes Biochim Biophys Acta 1609 2003 153 160
76. 2+-activated mitochondrial pores J Bioenerg Biomembr 33 2001 319 331
77. O.G. Mouritsen The liquid-ordered state comes of age Biochim Biophys Acta 1798 2010 1286 1288
78. S.P. Bhamidipati, and J.A. Hamilton Interactions of lyso 1-palmitoylphosphatidylcholine with phospholipids: a 13C and 31P NMR study Biochemistry 34 1995 5666 5677
79. V.V. Kumar, B. Malewicz, and W.J. Baumann Lysophosphatidylcholine stabilizes small unilamellar phosphatidylcholine vesicles. Phosphorus-31 NMR evidence for the "wedge" effect Biophys J 55 1989 789 792
80. S. Mabrey, and J.M. Sturtevant Incorporation of saturated fatty acids into phosphatidylcholine bilayers Biochim Biophys Acta 486 1977 444 450
81. M.C. Sandstrom, L.M. Ickenstein, L.D. Mayer, and K. Edwards Effects of lipid segregation and lysolipid dissociation on drug release from thermosensitive liposomes J Controlled Release 107 2005 131 142
82. a of the included fatty acid Langmuir 26 2010 12769 12776
83. K.R. Rosholm, A. Arouri, P.L. Hansen, A. Gonzalez-Perez, and O.G. Mouritsen Characterization of fluorinated catansomes: a promising vector in drug-delivery Langmuir 28 2012 2773 2781
84. P. Mukerjee, and K.J. Mysels Critical micelle concentrations of aqueous surfactant systems 1971 US Dept. of Commerce, National Bureau of Standards Washington, DC
85. R.E. Stafford, T. Fanni, and E.A. Dennis Interfacial properties and critical micelle concentration of lysophospholipids Biochemistry 28 1989 5113 5120
86. H. Matsuki, E. Miyazaki, F. Sakano, N. Tamai, and S. Kaneshina Thermotropic and barotropic phase transitions in bilayer membranes of ether-linked phospholipids with varying alkyl chain lengths Biochim Biophys Acta 1768 2007 479 489
87. C. Leidy, L. Linderoth, T.L. Andresen, O.G. Mouritsen, K. Jorgensen, and G.H. Peters Domain-induced activation of human phospholipase A2 type IIA: local versus global lipid composition Biophys J 90 2006 3165 3175
88. W.V. Kraske, and D.B. Mountcastle Effects of cholesterol and temperature on the permeability of dimyristoylphosphatidylcholine bilayers near the chain melting phase transition Biochim Biophys Acta 1514 2001 159 164
89. L.D. Mayer, R. Krishna, M. Webb, and M. Bally Designing liposomal anticancer drug formulations for specific therapeutic applications J Liposome Res 10 2000 99 115
90. T. Inoue, S. Yanagihara, Y. Misono, and M. Suzuki Effect of fatty acids on phase behavior of hydrated dipalmitoylphosphatidylcholine bilayer: saturated versus unsaturated fatty acids Chem Phys Lipids 109 2001 117 133
91. I. Vattulainen, and O.G. Mouritsen Diffusion in membranes P. Heitjans, J. Kärger, Diffusion in condensed matter 2005 Springer-Verlag Berlin Heidelberg
92. K. Lohner New strategies for novel antibiotics: peptides targeting bacterial cell membranes Gen Physiol Biophys 28 2009 105 116
93. B. Bechinger Insights into the mechanisms of action of host defence peptides from biophysical and structural investigations J Pept Sci 17 2011 306 314
94. V. Teixeira, M.J. Feio, and M. Bastos Role of lipids in the interaction of antimicrobial peptides with membranes Prog Lipid Res 51 2012 149 177
95. M.N. Jones Surfactants in membrane solubilisation Int J Pharm 177 1999 137 159
96. P. Garidel, A. Hildebrand, K. Knauf, and A. Blume Membranolytic activity of bile salts: influence of biological membrane properties and composition Molecules 12 2007 2292 2326
97. H. Heerklotz Interactions of surfactants with lipid membranes Q Rev Biophys 41 2008 205 264
98. J.N. Israelachvili Intermolecular and surface forces 2010 Academic Press Amsterdam Waltham, MA
99. R.S. Cantor Lipid composition and the lateral pressure profile in bilayers Biophys J 76 1999 2625 2639
100. N. Fuller, and R.P. Rand The influence of lysolipids on the spontaneous curvature and bending elasticity of phospholipid membranes Biophys J 81 2001 243 254
101. S.J. Marrink, A.H. de Vries, and D.P. Tieleman Lipids on the move: simulations of membrane pores, domains, stalks and curves Biochim Biophys Acta 1788 2009 149 168
102. B. Bechinger The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy Biochim Biophys Acta 1462 1999 157 183
103. M. Mihajlovic, and T. Lazaridis Antimicrobial peptides in toroidal and cylindrical pores Biochim Biophys Acta 1798 2010 1485 1493
104. D. Sengupta, H. Leontiadou, A.E. Mark, and S.J. Marrink Toroidal pores formed by antimicrobial peptides show significant disorder Biochim Biophys Acta 1778 2008 2308 2317
105. F. Yoneyama, Y. Imura, K. Ohno, T. Zendo, J. Nakayama, and K. Matsuzaki Peptide-lipid huge toroidal pore, a new antimicrobial mechanism mediated by a lactococcal bacteriocin, lacticin Q Antimicrob Agents Chemother 53 2009 3211 3217
106. K. Matsuzaki, Y. Mitani, K.-Y. Akada, O. Murase, S. Yoneyama, and M. Zasloff Mechanism of synergism between antimicrobial peptides Magainin 2 and PGLa Biochemistry 37 1998 15144 15153
107. B. Bechinger, and K. Lohner Detergent-like actions of linear amphipathic cationic antimicrobial peptides Biochim Biophys Acta 1758 2006 1529 1539
108. F. Campelo, and A. Hernandez-Machado Model for curvature-driven pearling instability in membranes Phys Rev Lett 99 2007 088101 88104
109. Y.A. Domanov, and P.K. Kinnunen Antimicrobial peptides temporins B and L induce formation of tubular lipid protrusions from supported phospholipid bilayers Biophys J 91 2006 4427 4439
110. P. Caccin, O. Rossetto, and C. Montecucco Neurotoxicity of inverted-cone shaped lipids Neurotoxicology 30 2009 174 181
111. F. Kamp, D. Zakim, F. Zhang, N. Noy, and J.A. Hamilton Fatty acid flip-flop in phospholipid bilayers is extremely fast Biochemistry 34 1995 11928 11937
112. C.W. Haest, G. Plasa, and B. Deuticke Selective removal of lipids from the outer membrane layer of human erythrocytes without hemolysis. Consequences for bilayer stability and cell shape Biochim Biophys Acta 649 1981 701 708
113. M.A. Gijon, and C.C. Leslie Regulation of arachidonic acid release and cytosolic phospholipase A2 activation J Leukocyte Biol 65 1999 330 336
114. P.D. Berk, and D.D. Stump Mechanisms of cellular uptake of long chain free fatty acids Mol Cell Biochem 192 1999 17 31
115. J. Lunn, and H.E. Theobald The health effects of dietary unsaturated fatty acids Nutr Bull 31 2006 178 224
116. H. Shimano Novel qualitative aspects of tissue fatty acids related to metabolic regulation: lessons from Elovl6 knockout Prog Lipid Res 51 2012 267 271
117. J.P. Little, J.M. Madeira, and A. Klegeris The saturated fatty acid palmitate induces human monocytic cell toxicity toward neuronal cells: exploring a possible link between obesity-related metabolic impairments and neuroinflammation J Alzheimers Dis 30 2012 S179 S183
118. J.Y. Lee, L. Zhao, and D.H. Hwang Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids Nutr Rev 68 2010 38 61
119. E.A. Schwartz, W.Y. Zhang, S.K. Karnik, S. Borwege, V.R. Anand, and P.S. Laine Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation Arterioscler, Thromb, Vasc Biol 30 2010 802 808
120. S. Nakamura, T. Takamura, N. Matsuzawa-Nagata, H. Takayama, H. Misu, and H. Noda Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria J Biol Chem 284 2009 14809 14818
121. G. Riccardi, R. Giacco, and A.A. Rivellese Dietary fat, insulin sensitivity and the metabolic syndrome Clin Nutr 23 2004 447 456
122. D.S. Im Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs Prog Lipid Res 51 2012 232 237
123. S.C. Frasch, and D.L. Bratton Emerging roles for lysophosphatidylserine in resolution of inflammation Prog Lipid Res 51 2012 199 207
124. D. Mehta Lysophosphatidylcholine: an enigmatic lysolipid Am J Physiol Lung Cell Mol Physiol 289 2005 L174 L175
125. J.W. Choi, D.R. Herr, K. Noguchi, Y.C. Yung, C.W. Lee, and T. Mutoh LPA receptors: subtypes and biological actions Annu Rev Pharmacol Toxicol 50 2010 157 186
126. J.H. Kabarowski G2A and LPC: regulatory functions in immunity Prostaglandins Other Lipid Mediat 89 2009 73 81
127. A. Wang, and E.A. Dennis Mammalian lysophospholipases Biochim Biophys Acta 1439 1999 1 16
128. R.E. Stafford, and E.A. Dennis Lysophospholipids as biosurfactants Colloids Surf 30 1987 47 64
129. X. Ye Lysophospholipid signaling in the function and pathology of the reproductive system Hum Reprod Update 14 2008 519 536
130. M. Rigoni, P. Caccin, S. Gschmeissner, G. Koster, A.D. Postle, and O. Rossetto Equivalent effects of snake PLA2 neurotoxins and lysophospholipid-fatty acid mixtures Science 310 2005 1678 1680
131. R. Wu, Y.H. Huang, L.S. Elinder, and J. Frostegård Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL Arterioscler, Thromb, Vasc Biol 18 1998 626 630
132. M.M. Murph, W. Liu, S. Yu, Y. Lu, H. Hall, and B.T. Hennessy Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis PLoS One 4 2009 e5583
133. F.C. Reman, R.A. Demel, and J. Degier Vandeene Ll, Eibl H, Westphal O. Studies on lysis of red cells and bimolecular lipid leaflets by synthetic lysolecithins, lecithins and structural analogs Chem Phys Lipids 3 1969 221 233
134. H.U. Weltzien Cytolytic and membrane-perturbing properties of lysophosphatidylcholine Biochim Biophys Acta 559 1979 259 287
135. J.A. Lapre, D.S. Termont, A.K. Groen, and R. Van der Meer Lytic effects of mixed micelles of fatty acids and bile acids Am J Physiol 263 1992 G333 G337
136. T.L. Andresen, S.S. Jensen, R. Madsen, and K. Jorgensen Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue J Med Chem 48 2005 7305 7314
137. M. Traikia, C. Marbeuf-Gueye, E. Hantz, and L. Le Moyec Impact of exogenous lysolipids on sensitive and multidrug resistant K562 cells: 1H NMR studies Chem-Biol Interact 151 2005 83 94
138. C.C. Hsieh, M.H. Yen, H.W. Liu, and Y.T. Lau Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL Atherosclerosis 151 2000 481 491
139. J.Y. Kong, and S.W. Rabkin Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin A Biochim Biophys Acta 1485 2000 45 55
140. G.C. Sparagna, D.L. Hickson-Bick, L.M. Buja, and J.B. McMillin A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis Am J Physiol Heart Circ Physiol 279 2000 H2124 H2132
141. A.H. van der Luit, M. Budde, P. Ruurs, M. Verheij, and W.J. van Blitterswijk Alkyl-lysophospholipid accumulates in lipid rafts and induces apoptosis via raft-dependent endocytosis and inhibition of phosphatidylcholine synthesis J Biol Chem 277 2002 39541 39547
142. R.S. Pardini Nutritional intervention with omega-3 fatty acids enhances tumor response to anti-neoplastic agents Chem-Biol Interact 162 2006 89 105
143. L.A. Sauer, R.T. Dauchy, and D.E. Blask Mechanism for the antitumor and anticachectic effects of n-3 fatty acids Cancer Res 60 2000 5289 5295
144. N.M. Harris, W.R. Anderson, B.A. Lwaleed, A.J. Cooper, B.R. Birch, and L.Z. Solomon Epirubicin and meglumine gamma-linolenic acid: a logical choice of combination therapy for patients with superficial bladder carcinoma Cancer 97 2003 71 78
145. X. Kong, H. Ge, L. Chen, Z. Liu, Z. Yin, and P. Li Gamma-linolenic acid modulates the response of multidrug-resistant K562 leukemic cells to anticancer drugs Toxicol in Vitro 23 2009 634 639
146. U.N. Das, N. Madhavi, G.S. Kumar, M. Padma, and P. Sangeetha Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites? Prostaglandins, Leukotrienes Essent Fatty Acids 58 1998 39 54
147. C.L. Davies, M. Loizidou, A.J. Cooper, and I. Taylor Effect of γ-linolenic acid on cellular uptake of structurally related anthracyclines in human drug sensitive and multidrug resistant bladder and breast cancer cell lines Eur J Cancer 35 1999 1534 1540
148. B.W. Lund, A.E. Knapp, F. Piu, N.K. Gauthier, M. Begtrup, and U. Hacksell Design, synthesis, and structure-activity analysis of isoform-selective retinoic acid receptor beta ligands J Med Chem 52 2009 1540 1545
149. B.W. Lund, F. Piu, N.K. Gauthier, A. Eeg, E. Currier, and V. Sherbukhin Discovery of a potent, orally available, and isoform-selective retinoic acid beta2 receptor agonist J Med Chem 48 2005 7517 7519
150. C. Foged, H.M. Nielsen, and S. Frokjaer Phospholipase A2 sensitive liposomes for delivery of small interfering RNA (siRNA) J Liposome Res 17 2007 191 196
151. C. Foged, H.M. Nielsen, and S. Frokjaer Liposomes for phospholipase A(2) triggered siRNA release: preparation and in vitro test Int J Pharm 331 2007 160 166
152. S.M. Marques, and J.C. Esteves da Silva Firefly bioluminescence. a mechanistic approach of luciferase catalyzed reactions IUBMB Life 61 2009 6 17
153. I. Mortimer, P. Tam, I. MacLachlan, R.W. Graham, E.G. Saravolac, and P.B. Joshi Cationic lipid-mediated transfection of cells in culture requires mitotic activity Gene Ther 6 1999 403 411
154. M. van Lummel, W.J. van Blitterswijk, S.R. Vink, R.J. Veldman, M.A. van der Valk, and D. Schipper Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors FASEB J 25 2011 280 289